Heart drug duel: which one keeps blood clots at bay?
NCT ID NCT06618976
First seen Feb 15, 2026 · Last updated Jun 11, 2026 · Updated 16 times
Summary
This study tested whether a newer heart medication (sotagliflozin) reduces blood clot formation better than an older one (empagliflozin) in 17 healthy volunteers. Each person took both drugs at different times, and researchers measured clot size and platelet activity. The goal was to understand if the newer drug might be safer for heart patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
Conditions
Explore the condition pages connected to this study.